Lonza to Invest $45 Million to Expand Vitamin B3 Capacity in China

Lonza says it will invest about SF50 million ($45 million) to build a new nicotinates (vitamin B3) manufacturing plant at the company’s existing production site at Nansha, China. The new facility will provide an additional 15,000 m.t./year of vitamin B3 capacity, an increase of more than 40% over current capacity. The investment will be made over the next three years, and the capacity will be added in phases with the first phase expected to come onstream in 2011, followed by full operation in 2012. Nicotinates, including both nicotinic acid and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers